{"name":"Ampio Pharmaceuticals","slug":"ampio","ticker":"AMPE","exchange":"NYSE American","domain":"ampiopharma.com","description":"Ampio Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapies for musculoskeletal and anti-inflammatory diseases. The company's lead product, Ampion, is a treatment for osteoarthritis and other inflammatory conditions. Ampio has a strong pipeline of products in various stages of development, with a focus on addressing unmet medical needs in the musculoskeletal and anti-inflammatory therapeutic areas. With a strong presence in the US market, Ampio is well-positioned to capitalize on the growing demand for effective treatments for these conditions.","hq":"Englewood, CO","founded":0,"employees":"","ceo":"Michael Macaluso","sector":"Musculoskeletal / Anti-Inflammatory","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$18M","metrics":{"revenue":1162462,"revenueGrowth":147.7,"grossMargin":0,"rdSpend":2439000,"netIncome":-8632000,"cash":5736000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2015"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Ampion patent cliff ($0.0B at risk)","drug":"Ampion","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Danazol Capsules","genericName":"Danazol Capsules","slug":"danazol-capsules","indication":"Other","status":"phase_2"},{"name":"Ampion","genericName":"Ampion","slug":"ampion","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Danazol Capsules","genericName":"Danazol Capsules","slug":"danazol-capsules","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ampion","genericName":"Ampion","slug":"ampion","phase":"discontinued","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Ampio Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Ampio Pharmaceuticals reported its financial results for the fourth quarter and full year 2023, with revenue of $1.4 million and a net loss of $13.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-09-06","type":"deal","headline":"Ampio Pharmaceuticals Announces Collaboration with Leading Research Institution to Develop New Therapies for Musculoskeletal Diseases","summary":"Ampio Pharmaceuticals announced a collaboration with a leading research institution to develop new therapies for musculoskeletal diseases, including osteoarthritis and rheumatoid arthritis.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBHUnpvMTNWVXg4ZDJkLVE1M2cwNUlqOVp5RTcxcndyMU5CcG9Tc1A0MEd4VHVnUWdHNWtvY0NaQnh5RnAxUVFoeVZZbVFZckVpekVB?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"AMPE Stock Price, News & Analysis - Stock Titan","headline":"AMPE Stock Price, News & Analysis","sentiment":"neutral"},{"date":"2025-01-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2024-03-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2024-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-02-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-02-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-01-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-01-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-12-01","type":"pipeline","source":"Dhaka Tribune","summary":"Ampio Pharma (NYSE: AMPE) up 194% y’day - and down 27% after hours - Dhaka Tribune","headline":"Ampio Pharma (NYSE: AMPE) up 194% y’day - and down 27% after hours","sentiment":"neutral"},{"date":"2023-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2023-11-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBuOENLR1c2Q0FWLTVxYnVBZU5TWHdxTnA2V1Q3NUxIM0pUSnAya0ZlWmZfa2N3VU1CQlBqT0ZKZkkzNzNEbEtLOGt3M01vRFZ5aVZfUTBOM1lLYVJsTlpEQjk1eFJWNk9YdGtRbW0zTVM0cUZY?oc=5","date":"2022-07-24","type":"pipeline","source":"Yahoo Finance","summary":"6 Penny Stocks With 1,000% Upside Potential - Yahoo Finance","headline":"6 Penny Stocks With 1,000% Upside Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOUTFneEVsS1ViXy1nNUdIc0hpY3hjOEkwc1djVkcyYmN3LWh6LWhjclZtMExGTy1DajhrZDJreVQxS1BrSktxUThDRFY1aE93djBKZEI4OGJ1bTVocDVzRVZqdUdOLWVrNXB2aUdmN3ZkaWlndXpqNk5lc0V4dmhCdmhyMkgwZVNFd2hQbW5pV21SVkdMYkNQaUQ1cWdYNG5ZMzVrVnlSTWJHcjBDOWFzNUlLUVppRnhXM3dfN1ZqU3hvcEtH?oc=5","date":"2021-11-10","type":"earnings","source":"BioSpace","summary":"Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update - BioSpace","headline":"Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOc2xTdDM0cXNXNW02ZHp4cl9BR2dvZUE2REFQcW9ISERvZmhCbjlmeWpLN2N3U2R6aGRJR1hTU21DZUhWbmJqMklubWR2cTFVM3hiVElDSzZjV202a1pWTTFVTUR6eEM3ZFNIeHhsX3AxaVVkYXptYm12WWpmNEIxNw?oc=5","date":"2020-04-28","type":"pipeline","source":"MarketBeat","summary":"Top NuCana (NCNA) Competitors 2026 - MarketBeat","headline":"Top NuCana (NCNA) Competitors 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOaVc0VmNUY09NbC1VTjB0RERNcFc5YlhEZEpQOEFSUlFQTWUyd0UzUVJJTTU0bVlzTGF2NjhoSkJkOWRFTERYdS1uRHJRdDFmSFhuVVE4SFU2MWM0RFlvTFl2cmRoZ0JUSk9SM3BVdDNweU5ndFVFa3U5OWMwWEVYVGVtTEFwa3Q5WkI3cFJJcGlhcTZpN0dzMGdtZDNNekw3elB4MFhRd0pqZkdLZmJLZnRPVWs1dEdCcS1zSEtzdXlLWWRfRjdwWklSN2p0cTJSSzk0MnNSZU1pUGx0RkwzRg?oc=5","date":"2019-08-22","type":"pipeline","source":"PR Newswire","summary":"Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee - PR Newswire","headline":"Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee","sentiment":"neutral"}],"patents":[{"drugName":"Ampion","drugSlug":"-ampion","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":0}],"drugCount":2,"phaseCounts":{"phase_2":1,"discontinued":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Johnson & Johnson","Pfizer","Merck & Co."],"therapeuticFocus":["Musculoskeletal","Anti-Inflammatory"],"financials":{"source":"sec_edgar+yahoo","revenue":1162462,"revenuePeriod":"2015-12-31","revenueHistory":[{"value":1162462,"period":"2015-12-31"},{"value":469213,"period":"2015-12-31"},{"value":487385,"period":"2015-09-30"},{"value":184435,"period":"2015-06-30"},{"value":21429,"period":"2015-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":2439000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-8632000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":5736000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}